Phytocannabinoids: a new frontier in Alzheimer’s disease management
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by cognitive decline and behavioral disturbances. The pathogenic characteristics encompass the existence of amyloid plaques outside the cells, neurofibrillary tangles inside the cells, neuroinflammation, oxidative stre...
Saved in:
Main Author: | Jagadeesh S. Rao |
---|---|
Format: | Article |
Language: | English |
Published: |
Academia.edu Journals
2024-09-01
|
Series: | Academia Biology |
Online Access: | https://www.academia.edu/124103477/Phytocannabinoids_a_new_frontier_in_Alzheimer_s_disease_management |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mitochondrial dysfunction in Alzheimer’s disease: a key frontier for future targeted therapies
by: Shuguang Wang, et al.
Published: (2025-01-01) -
New Frontiers /
by: Early, Margaret
Published: (1983) -
Social Media: The New Frontier for Human Resource Management in Asia
by: Ismi Rajiani, et al.
Published: (2024-01-01) -
Targeting Toll-like receptor 4 and microbiota dysregulation: a new frontier in nonalcoholic fatty liver disease management
by: K.B. Kvit
Published: (2024-12-01) -
Circuitry and Synaptic Dysfunction in Alzheimer’s Disease: A New Tau Hypothesis
by: Siddhartha Mondragón-Rodríguez, et al.
Published: (2020-01-01)